Nutraceutix Inc. Supplies D-Glucarate to Life Extension Foundation.

Business Editors & Health/Medical Writers

REDMOND, Wash.--(BW HealthWire)--Nov. 6, 2000

Nutraceutix Inc. (OTCBB: NUTX), a leading provider of proven technologies and products for the nutraceutical market, Monday announced it has sub-licensed and will supply patented Calcium D-Glucarate(TM) to Life Extension Foundation, of Fort Lauderdale, Fla., for Life Extension Mix, which will include 200mg of standardized calcium D-Glucarate per daily dose.

Nutraceutix holds the exclusive license of Calcium D-Glucarate for its benefits relating to breast, colon, liver, prostate and lung health. Life Extension Foundation sells product via its membership-based website, and provides health and product information through its monthly magazine, Life Extension.

"We feel that the inclusion of Calcium D-Glucarate in Life Extension Foundation's product is a outstanding match," stated David T. Howard, Nutraceutix president and chief executive officer. "Calcium D-Glucarate is a beneficial phytonutrient designed to facilitate one of the body's major detoxification and elimination pathways for potentially harmful environmental toxins.

"Life Extension Foundation has been advocating health and wellness for several decades, and Calcium D-Glucarate certainly fits nicely with their current product lineup."

Calcium D-Glucarate is the patented form of glucaric acid, a phytonutrient found naturally in grapefruit, apples, oranges, broccoli and brussel sprouts. Researchers have determined that supplemental Calcium D-Glucarate promotes glucuronidation, one of the major processes by which the body eliminates potentially harmful substances and chemicals; thereby, protecting it from environmental toxins.

Calcium D-Glucarate promotes health by inhibiting beta-glucuronidase, an enzyme that forms in the body and which hinders glucuronidation. If beta-glucuronidase levels go unchecked, they may not only reverse glucuronidation but allow toxins to remain in the body to potentially cause cell damage.

According to the cover story, "What's Missing From Multi-Vitamin Supplements?" in the November 2000 issue of Life Extension, beneficial phytonutrients, such as Calcium D-Glucarate, help combat the numerous carcinogens, such as pesticides, over-cooked food, alcohol, food additives, tobacco, fungal mutagens and industrial pollutants, the body is exposed to regularly.

D-Glucarate is distinguished from antioxidants in that it supports detoxification and elimination of potentially harmful toxins while providing protection against the "mutating effects that these carcinogens induce on cellular DNA."

Nutraceutix supplies Calcium D-Glucarate to quality companies in the nutritional supplement industry such as Boehringer Ingelheim, Enzymatic Therapy, Natrol, Nature's Way, Rexall Showcase, Twin Labs, Tyler Encapsulation, and many more. Nutraceutix' quality assurance program routinely monitors Calcium D-Glucarate products sold via U.S. retailers.

Nutraceutix has incorporated an identification marker on its Calcium D-Glucarate as part of its ongoing efforts to ensure consumers receive only the patented material, which is the material used in research and clinical studies conducted at the AMC Cancer Research Center, Denver, and MD Anderson Cancer Center, Houston.

Nutraceutix Inc. possesses proven technologies and products for the nutraceutical and pharmaceutical industries. In addition to patented ingredients like Calcium D-Glucarate, Nutraceutix provides patented and proprietary technologies including CDT(TM) Controlled Delivery Technology, MDT(TM)Molecular Dispersion Technology, SET(TM)Self Emulsifying Technology, and LiveBac(R)Probiotics.

Nutraceutix technologies provide distinctive supplements with competitive commercial advantages and tangible benefits for the consumer. Nutraceutix: Improving Nutrition. Improving Lives.

Except for any historical information, the matters discussed in this press release contain forward-looking statements, including activities, events or developments that the company expects, believes or anticipates will or may occur in the future. Such statements are subject to a number of assumptions, risks and uncertainties.

Readers are cautioned that such statements are not guarantees of future performance and that actual results or developments may differ materially from those set forth in the forward-looking statement.